Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease

Digestive Diseases and Sciences
Mark FleisherBrian G Feagan

Abstract

Approximately 15-20% of ulcerative colitis patients and 20-40% of those with Crohn's disease experience extraintestinal manifestations (EIMs) of their inflammatory bowel disease (IBD). Clinicians who treat IBD must manage EIMs affecting multiple organs that variably correlate with intestinal disease activity. Vedolizumab is a monoclonal antibody for the treatment of IBD with a gut-selective mechanism of action. This report evaluates whether vedolizumab is an effective treatment of EIMs, given its gut-specific mechanism of action. We report 8 case studies of patients with various EIMs, including pyoderma gangrenosum, peripheral arthralgia/arthritis, axial arthropathies, erythema nodosum, and uveitis, who received vedolizumab therapy. Vedolizumab therapy was effective for pyoderma gangrenosum in ulcerative colitis, uveitis, erythema nodosum, polyarticular arthropathy, and ankylosing spondylitis/sacroiliitis but did not provide sustained benefit for the treatment of pyoderma gangrenosum in a patient with Crohn's disease. These cases demonstrate the potential of vedolizumab as a treatment of EIMs in patients with IBD.

References

Oct 1, 1996·The British Journal of Dermatology·G J Nevitt, P E Hutchinson
Apr 24, 2001·The American Journal of Gastroenterology·C N BernsteinN Yu
Aug 9, 2003·The American Journal of Gastroenterology·Miguel RegueiroGary R Lichtenstein
Aug 29, 2006·World Journal of Gastroenterology : WJG·Katja S RothfussKlaus R Herrlinger
May 27, 2009·World Journal of Gastroenterology : WJG·Fabiola AtzeniPiercarlo Sarzi-Puttini
Dec 4, 2009·The American Journal of Gastroenterology·David A Schwartz
Apr 16, 2010·The New England Journal of Medicine·Jean Frédéric ColombelUNKNOWN SONIC Study Group
Oct 25, 2012·Digestion·Peter L LakatosStephan Vavricka
Jul 17, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jean-Frédéric ColombelJingdong Chao
Aug 24, 2013·The New England Journal of Medicine·Brian G FeaganUNKNOWN GEMINI 1 Study Group
Aug 24, 2013·The New England Journal of Medicine·William J SandbornUNKNOWN GEMINI 2 Study Group
Dec 5, 2013·World Journal of Clinical Cases·Maddalena ZippiPaolo Paoluzi
Jul 15, 2015·Inflammatory Bowel Diseases·Stephan R VavrickaGerhard Rogler
Aug 26, 2015·The American Journal of Gastroenterology·L Peyrin-BirouletJ-F Colombel
Nov 29, 2015·Journal of Crohn's & Colitis·Marcus HarbordUNKNOWN European Crohn’s and Colitis Organisation
Feb 20, 2016·Gut·Jean-Frédéric ColombelBrian G Feagan
May 31, 2016·World Journal of Gastroenterology : WJG·Mariabeatrice PrincipiAlfredo Di Leo
Jun 3, 2016·Journal of Crohn's & Colitis·Tim WyantBrihad Abhyankar
Jul 10, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Laurent Peyrin-BirouletSumesh Kachroo
Sep 8, 2016·The New England Journal of Medicine·Glenn J JaffeEric B Suhler
Sep 19, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Brian G FeaganMichael Smyth
Oct 25, 2016·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Philippe A R R Pijls, Lennard P L Gilissen
Jan 11, 2017·Gastroenterology Research and Practice·Francesca A R SilvaRaquel F Leal

❮ Previous
Next ❯

Citations

Jul 28, 2018·The Journal of Dermatological Treatment·Fatima McKenzieAlex G Ortega-Loayza
Aug 18, 2018·Expert Review of Clinical Immunology·Carla FeliceAlessandro Armuzzi
Jan 4, 2019·International Wound Journal·Hakim Ben AbdallahRikke Bech
Mar 5, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Robert BattatBrian G Feagan
Feb 23, 2019·Expert Review of Gastroenterology & Hepatology·Thomas Greuter, Stephan R Vavricka
May 12, 2019·Journal of Crohn's & Colitis·Thomas ChateauLaurent Peyrin-Biroulet
Nov 22, 2019·ACG Case Reports Journal·Wenfei WangDavid T Rubin
Oct 1, 2020·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·R RongischS A Eming
Aug 7, 2019·Experimental Dermatology·Magdolna SzántóPéter Bai
Dec 26, 2019·Expert Review of Clinical Pharmacology·Mohamad GoldustAlex G Ortega-Loayza
Jul 23, 2020·Therapeutic Advances in Gastroenterology·Fabiana ZingoneEdoardo Vincenzo Savarino
May 28, 2019·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Yun Sung Kim, Jun Lee
Oct 12, 2020·Clinical Journal of Gastroenterology·Aiko IkeuchiMuneaki Matsuo
Nov 20, 2020·Dermatitis : Contact, Atopic, Occupational, Drug·Gaetano LicataGiuseppe Argenziano
Apr 6, 2021·Frontiers in Immunology·Dennis McGonagleCharlie Bridgewood
Aug 14, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Francesca PenaginiGian Vincenzo Zuccotti
Sep 11, 2021·Current Opinion in Ophthalmology·Priya Janardhana, Saad Al-Kadhi

❮ Previous
Next ❯

Methods Mentioned

BETA
CHARM
biopsies
ESR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.